CurrentPartnering

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Research Reports By CurrentPartnering

Found 515 publications
Global Autism Partnering 2010-2016 US$ 1,495.00 Sep, 2016 100 pages
Global Rheumatoid Arthritis Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 200 pages
Global Lymphoma Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 150 pages
Global Dry Eye Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Alzheimer's Disease Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Medivation Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Fresenius Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials US$ 3,495.00 Sep, 2016 800 pages
Pfizer Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Dainippon Sumitomo Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Sexually Transmitted Diseases Partnering 2010-2016 US$ 1,495.00 Sep, 2016 150 pages
Global Systemic Lupus Erythematosus Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Myocardial Infarction Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Hearing Disorders Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Breast Cancer Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 150 pages
Covidien Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
PDL BioPharma Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Alexion Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Hospital Care Partnering 2010-2016: Deal trends, players and financials US$ 3,495.00 Sep, 2016 900 pages
Global Viral Partnering 2010-2016: Deal trends, players and financials US$ 2,995.00 Sep, 2016 500 pages
Teva Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Gilead Sciences Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Actavis Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Autoimmune Partnering 2010-2016: Deal trends, players and financials US$ 2,995.00 Sep, 2016 700 pages
Global Tuberculosis Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Obesity Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Human Papilloma Virus Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Colorectal Cancer Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 150 pages
Smith & Nephew Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Seattle Genetics Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Anika Therapeutics Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Ophthalmics Partnering 2010-2016: Deal trends, players and financials US$ 2,995.00 Sep, 2016 500 pages
Global Sexual Health Partnering 2010-2016: Deal trends, players and financials US$ 2,995.00 Sep, 2016 250 pages
Kyowa Hakko Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Apotex Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials US$ 2,995.00 Sep, 2016 500 pages
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 US$ 1,995.00 Sep, 2016 432 pages
Global Prenatal Screening Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Learning Disability Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Depression Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Acne Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Dendreon Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Elan Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Sensory Organ Partnering 2010-2016: Deal trends, players and financials US$ 2,995.00 Sep, 2016 200 pages
Novartis Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Celgene Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Pneumonia Partnering 2010-2016 US$ 1,495.00 Sep, 2016 150 pages
Global Molecular Diagnostics 2010-2016: Deal trends, players, financials and forecasts US$ 2,995.00 Sep, 2016 447 pages
Global Sleep Disorders Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 100 pages
Global Motor Neurone Disease Partnering 2010 to 2016 US$ 1,495.00 Sep, 2016 150 pages
1 2 3 4 5 ... 11
Skip to top

Analytics, News & Press-Releases by CurrentPartnering